Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells

References

Page 1

	Year	Citations
Global cancer statistics Ahmedin Jemal, Freddie Bray CA A Cancer Journal for Clinicians	2011	55K
Global Cancer Statistics, 2002 Donald Maxwell Parkin, Freddie Bray, Jacques Ferlay, CA A Cancer Journal for Clinicians Epidemiology Of CancerWorldwide IncidenceCancer RegistrationCancer DeathCancer Risk Factors	2005	18.4K
Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Ralf Buettner, Linda Mora, Richard Jove PubMed Signal TransducersImmunologyParticular Stat3Cancer BiologyTumor Biology	2002	1K
Phase III Trial of Doxorubicin, Paclitaxel, and the Combination of Doxorubicin and Paclitaxel as Front-Line Chemotherapy for Metastatic Breast Cancer: An Intergroup Trial (E1193) George W. Sledge, Donna Neuberg, Patricia Bernardo, Journal of Clinical Oncology	2003	701
Activation of nuclear factor-κB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide Suwei Wang, Srigiridhar Kotamraju, Eugene A. Konorev, Biochemical Journal Endothelial CellsLipid PeroxidationApoptosisImmunologyCell Death	2002	289
Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana Jayaprakasam Bolleddula, Navindra P. Seeram, Muraleedharan G. Nair Cancer Letters PharmacologyCucurbita AndreanaMedicinal ChemistryAntibacterial Agent	2002	283
Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line CW Taylor, WS Dalton, PR Parrish, British Journal of Cancer Different MechanismsBreast OncologyHealth SciencesDecreased Drug AccumulationMitoxantrone Resistant Variants	1991	162
Tamoxifen-Induced Rapid Death of MCF-7 Breast Cancer Cells Is Mediated via Extracellularly Signal-Regulated Kinase Signaling and Can Be Abrogated by Estrogen Aiping Zheng, Anu Kallio, Pirkko Härkönen Endocrinology	2007	156
The STAT3 oncogene as a predictive marker of drug resistance Benjamin Barré, Arnaud Vigneron, Neil D. Perkins, Trends in Molecular Medicine MedicineResistance Mutation (Virology)PharmacogenomicsPharmacotherapySystems Biology	2006	118
Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line Marzia Bruna Gariboldi, Raffaella Ravizza, Roberta Molteni, Cancer Letters Breast OncologyMedicineStat3 IncreasesBreast CancerCancer Biology	2007	85

Page 1